Kf. Schulz et al., EMPIRICAL-EVIDENCE OF BIAS - DIMENSIONS OF METHODOLOGICAL QUALITY ASSOCIATED WITH ESTIMATES OF TREATMENT EFFECTS IN CONTROLLED TRIALS, JAMA, the journal of the American Medical Association, 273(5), 1995, pp. 408-412
Objective.-To determine if inadequate approaches to randomized control
led trial design and execution are associated with evidence of bias in
estimating treatment effects. Design.-An observational study in which
we assessed the methodological quality of 250 controlled trials from
33 meta-analyses and then analyzed, using multiple logistic regression
models, the associations between those assessments and estimated trea
tment effects. Data Sources.-Meta-analyses from the Cochrane Pregnancy
and Childbirth Database. Main Outcome Measures.-The associations betw
een estimates of treatment effects and inadequate allocation concealme
nt, exclusions after randomization, and lack of double-blinding. Resul
ts.-Compared with trials in which authors reported adequately conceale
d treatment allocation, trials in which concealment was either inadequ
ate or unclear (did not report or incompletely reported a concealment
approach) yielded larger estimates of treatment effects (P<.001). Odds
ratios were exaggerated by 41% for inadequately concealed trials and
by 30% for unclearly concealed trials (adjusted for other aspects of q
uality). Trials in which participants had been excluded after randomiz
ation did not yield larger estimates of effects, but that lack of asso
ciation may be due to incomplete reporting. Trials that were not doubl
e-blind also yielded larger estimates of effects (P=.01), with odds ra
tios being exaggerated by 17%. Conclusions.-This study provides empiri
cal evidence that inadequate methodological approaches in controlled t
rials, particularly those representing poor allocation concealment, ar
e associated with bias. Readers of trial reports should be wary of the
se pitfalls, and investigators must improve their design, execution, a
nd reporting of trials.